Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly

Clinical Endocrinology

Volumn 56, Issue 3, 2002, Pages 313-319

  Biermasz, Nienke R ^a   Smit, Jan W A ^a   Van Dulken, Hans ^a   Roelfsema, Ferdinand ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN; PROTIRELIN; SOMATOMEDIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; GROWTH HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RISK FACTOR; STIMULATION; THYROTROPIN RELEASE;

ACROMEGALY; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; RECURRENCE; THYROTROPIN-RELEASING HORMONE; TREATMENT OUTCOME;

EID: 0036223983     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01465.x     Document Type: Article

References (28)

1. 2), GH-releasing hormone, and thyrotrophin-releasing hormone in acromegaly
2. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism
3. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly
4. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly
5. An audit of outcome of treatment in acromegaly
6. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly
7. Long term follow-up results of postoperative radiotherapy in 36 patients with acromegaly
8. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients
9. Paradoxical growth hormone response to thyrotrophin-releasing hormone in acromegaly. Clinical correlations and prognostic value
10. Acromegaly
11. Evaluation of the results of transsphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone
12. Surgical management of acromegaly
13. Transsphenoidal microsurgical treatment of acromegaly
14. Treatment of acromegaly by transsphenoidal microsurgery
15. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly
16. Treatment of acromegaly: Radiation of surgery?
17. Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly
18. A low starting dose of genotropin in growth hormone-deficient adults
19. Effects of repetitive administration of thyrotrophin-releasing hormone at short intervals in acromegaly
20. Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: Results in 230 patients
21. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients
22. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients
23. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly
24. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
25. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: A report on 39 patients
26. Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: Results and follow-up
27. Growth hormone response to thyrotrophin-releasing hormone in acromegalic patients: Reproducibility and dose-response study
28. Long-term growth hormone responses to nonspecific hypothalamic hormones in acromegalic patients